Demonstrate Bioequivalence Between 3 x 2-mg Tablets of Perampanel and a Single 6-mg Tablet of Perampanel in Healthy Subjects
Clinical trial NCT01396577 · COMPLETED
Trial details
- NCT number
- NCT01396577
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-03-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.